Sign in
8-K

Current Report

Avalo Therapeutics, Inc. Filed Acc 0001628280-23-032187

Material agreement

  • Item 1.01 Entry into a material definitive agreement

From the SEC's structured data for this filing

Loading avtx-20230913.htm…